ADIAL PHARMACEUTICALS, INC. Insider Trading for August 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ADIAL PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ADIAL PHARMACEUTICALS, INC. for August 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | P | 6.25 | 80,000 | 500,000 | 169,027 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | J | 5.00 | 36,800 | 184,000 | 36,800 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | C | 6.25 | 52,227 | 326,419 | 89,027 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | J | 6.25 | 36,800 | 230,000 | 36,800 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Option Exercise | C | 0.44 | 52,227 | 22,980 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Buy | P | 0.00 | 80,000 | 0 | 504,000 | 424 K to 504 K (+18.87 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Buy | C | 0.00 | 52,227 | 0 | 424,629 | 372.4 K to 424.6 K (+14.02 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Stilley William B. III | Chief Executive Off ... | Buy | J | 0.00 | 36,800 | 0 | 372,402 | 335.6 K to 372.4 K (+10.97 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 5.00 | 162,200 | 811,000 | 162,200 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 5.00 | 120,000 | 600,000 | 120,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 6.25 | 113,800 | 711,250 | 113,800 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | P | 6.25 | 90,000 | 562,500 | 292,461 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | J | 6.25 | 120,000 | 750,000 | 202,461 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | C | 6.25 | 82,461 | 515,381 | 82,461 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Option Exercise | C | 0.44 | 82,461 | 36,283 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Buy | J | 0.00 | 113,800 | 0 | 113,800 | 0 to 113.8 K |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Buy | P | 0.00 | 90,000 | 0 | 343,390 | 253.4 K to 343.4 K (+35.52 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Buy | J | 0.00 | 120,000 | 0 | 253,390 | 133.4 K to 253.4 K (+89.96 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Schuyler Kevin | Director | Buy | C | 0.00 | 82,461 | 0 | 133,390 | 50.9 K to 133.4 K (+161.91 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | P | 6.25 | 10,000 | 62,500 | 10,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | P | 6.25 | 10,000 | 62,500 | 102,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 92,000 | 460,000 | 92,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 5.00 | 20,000 | 100,000 | 20,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 92,000 | 575,000 | 92,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 20,000 | 125,000 | 25,178 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 5,178 | 32,363 | 5,178 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 21,715 | 135,719 | 21,715 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | J | 6.25 | 29,931 | 187,069 | 29,931 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | C | 0.44 | 5,178 | 2,278 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | C | 0.44 | 21,715 | 9,555 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Option Exercise | C | 0.44 | 29,931 | 13,170 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | P | 0.00 | 10,000 | 0 | 150,419 | 140.4 K to 150.4 K (+7.12 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | J | 0.00 | 92,000 | 0 | 140,419 | 48.4 K to 140.4 K (+190.01 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | J | 0.00 | 20,000 | 0 | 35,094 | 15.1 K to 35.1 K (+132.50 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | C | 0.00 | 5,178 | 0 | 15,221 | 10 K to 15.2 K (+51.56 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | C | 0.00 | 21,715 | 0 | 58,419 | 36.7 K to 58.4 K (+59.16 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Newman James W. Jr. | Director | Buy | C | 0.00 | 29,931 | 0 | 41,160 | 11.2 K to 41.2 K (+266.55 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Goodman Tony | Director | Option Exercise | P | 6.25 | 7,000 | 43,750 | 7,000 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Goodman Tony | Director | Buy | P | 0.00 | 7,000 | 0 | 8,755 | 1.8 K to 8.8 K (+398.86 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Option Exercise | P | 6.25 | 14,000 | 87,500 | 43,931 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Option Exercise | C | 6.25 | 29,931 | 187,069 | 29,931 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Option Exercise | C | 0.44 | 29,931 | 13,170 | 0 | |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Buy | P | 0.00 | 14,000 | 0 | 109,424 | 95.4 K to 109.4 K (+14.67 %) |
| Aug 02 2018 | ADIL | ADIAL PHARMACEUTIC ... | Gilliland Robertson H. | Director | Buy | C | 0.00 | 29,931 | 0 | 95,424 | 65.5 K to 95.4 K (+45.70 %) |